Content Status
Type
Linked Node
Isoniazid [H] Mono/Poly DR-TB Regimen: Pre-treatment Evaluation
Learning ObjectivesIsoniazid [H] Mono/Poly DR-TB Regimen: Pre-treatment Evaluation
Pre-treatment evaluation for any TB patient must include a thorough clinical evaluation by a doctor with:
- History and physical examination
- Height/ weight check
- Random Blood Sugar (RBS)
- Chest X-ray
- HIV test
No additional investigations (except the basic evaluations mentioned above) are required for Isoniazid (H) mono/ poly Drug-resistant TB (DR-TB) patients unless clinically indicated.
The pre-treatment evaluation carried out at the time of treatment initiation can be considered valid for 1 month from the date of the test result and the patient can be reinitiated on a subsequent regimen considering the previously conducted pre-treatment tests.
Active Drug Safety Management and Monitoring (aDSM) treatment initiation form needs to be completed for all DR-TB patients at the time of initiation of each new episode of the treatment.
Resources
- Guidelines for Programmatic Management of Drug-resistant Tuberculosis in India, March 2021.
- WHO Consolidated Guidelines on Tuberculosis: Module 4 - Treatment: Drug-resistant TB Treatment, 2020.
Kindly provide your valuable feedback on the page to the link provided HERE
Content Creator
Reviewer
Target Audience
- Log in to post comments